| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2269 | 2019 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2163 | 2011 |
| The ageing systemic milieu negatively regulates neurogenesis and cognitive function SA Villeda, J Luo, KI Mosher, B Zou, M Britschgi, G Bieri, TM Stan, ... Nature 477 (7362), 90-94, 2011 | 1868 | 2011 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1372 | 2018 |
| Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression M Manczak, TS Anekonda, E Henson, BS Park, J Quinn, PH Reddy Human molecular genetics 15 (9), 1437-1449, 2006 | 1352 | 2006 |
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ... Nature medicine 13 (11), 1359-1362, 2007 | 1293 | 2007 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 922 | 2017 |
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial JF Quinn, R Raman, RG Thomas, K Yurko-Mauro, EB Nelson, C Van Dyck, ... Jama 304 (17), 1903-1911, 2010 | 902 | 2010 |
| DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ... Brain 133 (3), 713-726, 2010 | 735 | 2010 |
| Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease M Shi, C Liu, TJ Cook, KM Bullock, Y Zhao, C Ginghina, Y Li, P Aro, ... Acta neuropathologica 128, 639-650, 2014 | 636 | 2014 |
| Lipid peroxidation in aging brain and Alzheimer’s disease TJ Montine, MD Neely, JF Quinn, MF Beal, WR Markesbery, LJ Roberts II, ... Free Radical Biology and Medicine 33 (5), 620-626, 2002 | 563 | 2002 |
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ... Archives of neurology 67 (12), 1473-1484, 2010 | 503 | 2010 |
| YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease R Craig-Schapiro, RJ Perrin, CM Roe, C Xiong, D Carter, NJ Cairns, ... Biological psychiatry 68 (10), 903-912, 2010 | 497 | 2010 |
| Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression M Shi, J Bradner, AM Hancock, KA Chung, JF Quinn, ER Peskind, ... Annals of neurology 69 (3), 570-580, 2011 | 480 | 2011 |
| Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders F Abdi, JF Quinn, J Jankovic, M McIntosh, JB Leverenz, E Peskind, ... Journal of Alzheimer's Disease 9 (3), 293-348, 2006 | 472 | 2006 |
| Cerebrospinal fluid tau and β-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? CM Clark, S Xie, J Chittams, D Ewbank, E Peskind, D Galasko, JC Morris, ... Archives of neurology 60 (12), 1696-1702, 2003 | 471 | 2003 |
| Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis DJ Irwin, M Grossman, D Weintraub, HI Hurtig, JE Duda, SX Xie, EB Lee, ... The Lancet Neurology 16 (1), 55-65, 2017 | 454 | 2017 |
| Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains DM Zeppenfeld, M Simon, JD Haswell, D D’Abreo, C Murchison, JF Quinn, ... JAMA neurology 74 (1), 91-99, 2017 | 454 | 2017 |
| Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease AE Roher, CL Esh, TA Kokjohn, EM Castaño, GD Van Vickle, WM Kalback, ... Alzheimer's & Dementia 5 (1), 18-29, 2009 | 440 | 2009 |
| Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease AS Fleisher, R Raman, ER Siemers, L Becerra, CM Clark, RA Dean, ... Archives of neurology 65 (8), 1031-1038, 2008 | 435 | 2008 |
